349 related articles for article (PubMed ID: 24035866)
1. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.
Costa-Guda J; Arnold A
Mol Cell Endocrinol; 2014 Apr; 386(1-2):46-54. PubMed ID: 24035866
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
[TBL] [Abstract][Full Text] [Related]
4. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
7. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid Tumors: Molecular Signatures.
Marini F; Giusti F; Iantomasi T; Brandi ML
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681865
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of primary hyperparathyroidism.
Cetani F; Pardi E; Borsari S; Marcocci C
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic insights into sporadic primary hyperparathyroidism.
Brewer K; Costa-Guda J; Arnold A
Endocr Relat Cancer; 2019 Feb; 26(2):R53-R72. PubMed ID: 30475215
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of parathyroid tumors.
Carling T
Trends Endocrinol Metab; 2001 Mar; 12(2):53-8. PubMed ID: 11167122
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
Newey PJ; Nesbit MA; Rimmer AJ; Attar M; Head RT; Christie PT; Gorvin CM; Stechman M; Gregory L; Mihai R; Sadler G; McVean G; Buck D; Thakker RV
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1995-2005. PubMed ID: 22855342
[TBL] [Abstract][Full Text] [Related]
14. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
Arnold A
Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
[TBL] [Abstract][Full Text] [Related]
15. HRPT2 mutational analysis of typical sporadic parathyroid adenomas.
Krebs LJ; Shattuck TM; Arnold A
J Clin Endocrinol Metab; 2005 Sep; 90(9):5015-7. PubMed ID: 15956079
[TBL] [Abstract][Full Text] [Related]
16. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
17. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.
Cromer MK; Starker LF; Choi M; Udelsman R; Nelson-Williams C; Lifton RP; Carling T
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1774-81. PubMed ID: 22740705
[TBL] [Abstract][Full Text] [Related]
18. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.
Cetani F; Pardi E; Borsari S; Viacava P; Dipollina G; Cianferotti L; Ambrogini E; Gazzerro E; Colussi G; Berti P; Miccoli P; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5583-91. PubMed ID: 15531515
[TBL] [Abstract][Full Text] [Related]
19. Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas.
Wei Z; Sun B; Wang ZP; He JW; Fu WZ; Fan YB; Zhang ZL
Endocrinology; 2018 Aug; 159(8):3061-3068. PubMed ID: 29982334
[TBL] [Abstract][Full Text] [Related]
20. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
